Sanger celebrates Highly Cited Researchers
A number of researchers from the Wellcome Sanger Institute have been named on Clarivate's Highly Cited list
The Wellcome Sanger Institute is proud to announce that nine of its current and former academics and three honorary or associate faculty members have been named on the annual Highly Cited Researchers™ 2021 list from Clarivate.
In addition, the five former Sanger researchers cited are Dr John Tate, Professor Gordon Dougan, Dr Simon Harris, Dr Alan Walker, and Dr Ludmil Alexandrov, who was previously a PhD student at the Institute.
Other scientists on the Highly Cited Researchers list include honorary faculty member, Dr Paul Flicek and associate faculty members, Dr Richard Durbin and Dr John Marioni.
The anticipated annual list identifies researchers who demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during the last decade. Their names are drawn from the publications that rank in the top one per cent by citations for field and publication year in the Web of Science™ citation index.
This year’s list includes 24 Nobel laureates, including five announced this year. Also included are 77 Citation Laureates™: individuals recognised by Clarivate, through citation analysis, as ‘of Nobel class’ and potential Nobel Prize recipients.
“It is increasingly important for nations and institutions to recognize and support the exceptional researchers who are driving the expansion of the world’s knowledge. This list identifies and celebrates exceptional individual researchers at the Wellcome Sanger Institute who are having a significant impact on the research community as evidenced by the rate at which their work is being cited by their peers. The research they have contributed is fueling the innovation, sustainability, health and security that is key for our society’s future.”
David Pendlebury, Senior Citation Analyst at the Institute for Scientific Information at Clarivate
“At the Sanger Institute, we are incredibly proud of all of our researchers, and the exceptional science that they produce. It is fantastic that so many of our present and past academics and faculty have been celebrated on the Highly Cited Researchers 2021 list, and I would like to congratulate them, and everyone else on the list, on this achievement. Research holds the answers to many ongoing questions and challenges around health and disease and it is vital that we continue to show our appreciation to those who are committed to pushing the boundaries to make these discoveries.”
Dr Julia Wilson, Associate Director at the Wellcome Sanger Institute
The full 2021 Highly Cited Researchers list and executive summary can be found online here.
The methodology that determines the “who’s who” of influential researchers draws on the data and analysis performed by bibliometric experts and data scientists at the Institute for Scientific Information™ at Clarivate. It also uses the tallies to identify the countries and research institutions where these citation elite are based.
Some truly extraordinary Highly Cited Researchers appear in more than one Essential Science Indicators (ESI)™ field. Of the researchers named as Highly Cited in the 21 ESI fields, 23 researchers showed exceptional broad performance, recognised for being highly cited in three or more fields. They are a truly global group – in North America, Europe, Asia and the Middle East.
Related blog posts
15 Nov 2021
Covid Connections - Big Data in a Pandemic World
Researchers discuss COVID-19 genome data and its complexities, data sharing and security, and their careers in data science
20 Sep 2021
Celebrating Sanger Postdocs
This week (20th-24th September) is Postdoc Appreciation Week - a time to celebrate the fantastic contribution postdoctoral scientists make.
26 Jan 2023
‘Collateral damage’ from normal cell function may cause mutations that play a role in cancer
APOBEC1 enzyme likely responsible for two mutational signatures found in many cancers in small intestine
19 Jan 2023
Bowel cancer mutations that impact immunotherapy identified
Researchers used CRISPR and mini tumours to discover more about how cancer develops and responds to the body’s immune response.